Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services

Contract Services

PTC Therapeutics agrees to buy Marathon's DMD drug for $140m PTC Therapeutics has agreed to acquire all rights to Emflaza (deflazacort) from Marathon Pharmaceuticals.
Contract Research & Services > Contract Services > News
Advaxis licenses antigen delivery technology to Sellas for cancer immunotherapy development Advaxis has licensed its Lm-based antigen delivery technology to Sellas, under a cancer immunotherapy collaboration that could generate up to $358m for Advaxis.
Contract Research & Services > Contract Services > News Horizon Discovery signs master service deal with top three global pharmaceutical firm Horizon Discovery Group has signed a Master Services Agreement (MSA) with a top three global pharmaceutical company, extending support for their drug discovery and development efforts to its full suite of services.
Contract Research & Services > Contract Services > News
See more Contract Services news

Latest Contract Services News and Insight

View all Contract Services news or find news targeted to your interests
NSF: Making Pharmaceuticals
NSF International will be exhibiting at Making Pharmaceuticals, the only dedicated free to attend event in the UK that addresses the detailed and complex issues associated with sourcing, manufacturing, outsourcing and delivering of consistent pharmaceutical products to the market.
Contract Research & Services > Contract Services > Press Releases
PTC Therapeutics agrees to buy Marathon's DMD drug for $140m
PTC Therapeutics has agreed to acquire all rights to Emflaza (deflazacort) from Marathon Pharmaceuticals.
Contract Research & Services > Contract Services > News
NSF: KPIs and the Head of Corporate Quality: KPIs Are Essential for a Successful Product Release
| By NSF Health Sciences Pharma Biotech PBR
What are your views on KPIs? Essential or a necessary evil? “They are absolutely essential, providing they are good! I remember during a regulatory inspection I was asked every QP’s most feared question: How do you know everything is in control before you release product?
Contract Research & Services > Contract Services > White Papers
NSF: Learn from a Fabulously Successful GMP Remediation Program
| By NSF Health Sciences Pharma Biotech PBR
This White Paper describes a remediation program that appeared at first to be impossibly daunting, expensive and unattainable. The company had received a range of critical and major GMP deficiencies from the UK regulatory body, MHRA, and was facing a referral to MHRA’s Inspection Action Group. Manufacturing had to be suspended pending a risk assessment of the non-compliances; evaluating the effect of the non-compliances in terms of risks of misbranding and adulteration of the products. Shifts were cancelled, the supply chain was suspended and an urgent remediation program begun.
Contract Research & Services > Contract Services > White Papers
NSF: Remediation of Pharma Quality Systems – It’s All About the People
| By NSF Health Sciences Pharma Biotech PBR
Much of NSF Pharma Biotech Consulting’s work involves helping companies remediate flawed quality systems. This is usually done as a result of threatened or actual enforcement action by regulatory agencies. In these circumstances, companies are desperate and willing to do ‘whatever it takes’ without a full understanding of what that means. While expansive in concept, ‘whatever it takes,’ for many, means simply deploying internal and external resources to design and document a new quality management system. This is a significant commitment by management in resources, but unless the cause (how did this happen?) is also considered, the effort is doomed to fail.
Contract Research & Services > Contract Services > White Papers
New Vetter Data Processing Center is Officially Certified
IT experts of TÜV Süd, a German industrial testing organization, have certified the new data processing center at Vetter's headquarters in Ravensburg, Germany. The pharmaceutical service provider has fulfilled all requirements to meet the "TÜV Süd certified data processing center" criteria.
Contract Research & Services > Contract Services > Press Releases
Vetter's Skokie Site Successfully Manufactures Batches on New Clinical Syringe Filling Line
Vetter, a leading international contract development and manufacturing organization (CDMO) that specializes in aseptic filling for its (bio-)pharmaceutical customers, has announced today that its new clinical syringe line has already manufactured for its customers a double digit number of batches for use in early clinical trials.
Contract Research & Services > Contract Services > Press Releases
Vetter Starts Operations in its Center for Visual Inspection and Logistics
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) for development, aseptic filling and final packaging of injectables, has announced today that it has begun operations in its expanded Visual Inspection and Logistics Center located in Ravensburg.
Contract Research & Services > Contract Services > Press Releases
View all Contract Services news or find news targeted to your interests